1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Stretch Marks Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment
6.1 Topical Products
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Creams
6.1.2.2 Oils and Serum
6.1.2.3 Lotions
6.1.3 Market Forecast
6.2 Lasers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Fractional Lasers
6.2.2.2 Pulse-Dye Lasers
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Microdermabrasion
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Institutional
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Supermarkets and Hypermarkets
7.2.2.2 Specialist Retailers
7.2.2.3 Medical Retailers
7.2.2.4 Online Stores
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Use
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Specialty Dermatology Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Alliance Pharma PLC
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 basq NYC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Candela Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Clarins
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Dermaclara
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 E.T. Browne Drug Co. Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Helix Biomedix Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 HRA Pharma (Perrigo Company plc)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Laboratoires Expanscience
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Union-Swiss (Pty) Ltd
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Weleda
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
世界のストレッチマーク治療市場予測2023年-2028年 |
| 【英語タイトル】Stretch Marks Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FE0141 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：141 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社の調査レポートによると、世界のストレッチマーク治療市場規模は2022年28億ドルに達しました。今後、2028年には41億ドルまで拡大し、2023年から2028年の間に年平均6.1％で成長すると予測されます。本レポートでは、ストレッチマーク治療の世界市場について調査・分析し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、治療別（局所製品、レーザー、マイクロダーマブレーション、その他）分析、流通チャネル別（機関、小売）分析、エンドユーザー別（病院＆クリニック、家庭用、専門皮膚科センター、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下の構成でお届けします。なお、本書には、Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.などの企業情報が含まれています。 ・序論 ・範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界のストレッチマーク治療市場規模：治療別 - 局所製品の市場規模 - レーザーの市場規模 - マイクロダーマブレーションの市場規模 - その他治療の市場規模 ・世界のストレッチマーク治療市場規模：流通チャネル別 - 機関チャネルの市場規模 - 小売チャネルの市場規模 ・世界のストレッチマーク治療市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - 家庭における市場規模 - 専門皮膚科センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のストレッチマーク治療市場規模：地域別 - 北米のストレッチマーク治療市場規模 - アジア太平洋のストレッチマーク治療市場規模 - ヨーロッパのストレッチマーク治療市場規模 - 中南米のストレッチマーク治療市場規模 - 中東・アフリカのストレッチマーク治療市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global stretch marks treatment market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.
Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome. Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.
Stretch Marks Treatment Market Trends:
The increasing incidence of obesity among the masses is one of the key factors driving the market growth. With the changing dietary patterns and the rising adoption of sedentary lifestyles, individuals are widely suffering from excessive weight gain, which is leading to the development of stretch marks. Moreover, the increasing product demand among pregnant women is favoring the market growth. Stretch marks lotions, oils and serums are fortified with essential oils and nutrients that aid in minimizing the visibility of stretched and broken skin and promote healing. Additionally, various product innovations, such as the launch of chemical peels, platelet-rich plasma (PRP), micro-needling, non-invasive microdermabrasion and laser-based treatment procedures, are providing a thrust to the market growth. These procedures aid in the breakdown of old collagen and promote the development of new skin tissues. Other factors, including the convenient availability of over-the-counter stretch marks ointments, along with the increasing consciousness among the masses regarding their physical appearance, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stretch marks treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment, distribution channel and end user.
Breakup by Treatment:
Topical Products
Creams
Oils and Serum
Lotions
Lasers
Fractional Lasers
Pulse-Dye Lasers
Others
Microdermabrasion
Others
Breakup by Distribution Channel:
Institutional
Retail
Supermarkets and Hypermarkets
Specialist Retailers
Medical Retailers
Online Stores
Others
Breakup by End User:
Hospitals and Clinics
Home Use
Specialty Dermatology Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.
Key Questions Answered in This Report
1. What was the size of the global stretch marks treatment market in 2022?
2. What is the expected growth rate of the global stretch marks treatment market during 2023-2028?
3. What are the key factors driving the global stretch marks treatment market?
4. What has been the impact of COVID-19 on the global stretch marks treatment market?
5. What is the breakup of the global stretch marks treatment market based on the treatment?
6. What is the breakup of the global stretch marks treatment market based on the end user?
7. What are the key regions in the global stretch marks treatment market?
8. Who are the key players/companies in the global stretch marks treatment market?
❖ レポートの目次 ❖
| ★調査レポート[世界のストレッチマーク治療市場予測2023年-2028年] (コード：IMARC23FE0141)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のストレッチマーク治療市場予測2023年-2028年]についてメールでお問い合わせ |
